A Study Protocol: a Community Pharmacy-based Intervention for Improving the Management of Sleep Disorders in the Community Settings

Overview

Journal BMC Health Serv Res

Publisher Biomed Central

Specialty Health Services

Date 2014 Feb 19

PMID 24533916

Citations 5

Authors

Zaswiza Mohamad Noor

Alesha J Smith

Simon S Smith

Lisa M Nissen

Affiliations

Soon will be listed here.

Abstract

Background: Sleep disorders are very common in the community and are estimated to affect up to 45% of the world's population. Pharmacists are in a position to give advice and provide appropriate services to individuals who are unable to easily access medical care. The purpose of this study is to develop an intervention to improve the management of sleep disorders in the community. The aims are- (1) to evaluate the effectiveness of a community pharmacy-based intervention in managing sleep disorders, (2) to evaluate the role of actigraph as an objective measure in monitoring certain sleep disorders and (3) to evaluate the extended role of community pharmacists in managing sleep disorders. This intervention is developed to monitor individuals undergoing treatment and overcome the difficulties in validating self-reported feedback.

Method/design: This is a community-based intervention, prospective, controlled trial, with one intervention group and one control group, comparing individuals receiving a structured intervention with those receiving usual care for sleep-related disorders at community pharmacies.

Discussion: This study will demonstrate the utilisation and efficacy of community pharmacy-based intervention to manage sleep disorders in the community, and will assess the possibility of implementing this intervention into the community pharmacy workflow.

Trial Registration: Australian New Zealand Clinical Trial Registry: ACTRN12612000825853.

Citing Articles

A survey assessing sleep efficiency among Saudis during COVID-19 home confinement using the Pittsburgh sleep quality index: A call for health education.

Alqahtani S, Banji D, Banji O Saudi Pharm J. 2021; 29(7):692-698.

PMID: 34400863 PMC: 8347667. DOI: 10.1016/j.jsps.2021.04.031.

Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.

Steed L, Sohanpal R, Todd A, Madurasinghe V, Rivas C, Edwards E Cochrane Database Syst Rev. 2019; 12:CD011207.

PMID: 31808563 PMC: 6896091. DOI: 10.1002/14651858.CD011207.pub2.

Hypnotic Effect of Red Cabbage () on Pentobarbital-Induced Sleep in Mice.

Hosseini A, Sobhanifar M, Forouzanfar F, Aghaee A, Rakhshandeh H J Pharm Bioallied Sci. 2018; 10(1):48-53.

PMID: 29657508 PMC: 5887652. DOI: 10.4103/jpbs.JPBS_215_17.

A feasibility study: Use of actigraph to monitor and follow-up sleep/wake patterns in individuals attending community pharmacy with sleeping disorders.

Mohamad Noor Z, Smith A, Smith S, Nissen L J Pharm Bioallied Sci. 2016; 8(3):173-80.

PMID: 27413344 PMC: 4929955. DOI: 10.4103/0975-7406.171739.

Strategies of Functional Foods Promote Sleep in Human Being.

Zeng Y, Yang J, Du J, Pu X, Yang X, Yang S Curr Signal Transduct Ther. 2015; 9(3):148-155.

PMID: 26005400 PMC: 4440346. DOI: 10.2174/1574362410666150205165504.

References

Crockett J, Taylor S . Rural pharmacist perceptions of a project assessing their role in the management of depression. Aust J Rural Health. 2009; 17(5):236-43. DOI: 10.1111/j.1440-1584.2009.01084.x. View

Lack L, Miller W, Turner D . A survey of sleeping difficulties in an Australian population. Community Health Stud. 1988; 12(2):200-7. DOI: 10.1111/j.1753-6405.1988.tb00161.x. View

Ely J, Khorfan F . Unilateral periorbital swelling with nasal CPAP therapy. J Clin Sleep Med. 2007; 2(3):330-1. View

Richard W, Venker J, den Herder C, Kox D, van den Berg B, Laman M . Acceptance and long-term compliance of nCPAP in obstructive sleep apnea. Eur Arch Otorhinolaryngol. 2007; 264(9):1081-6. DOI: 10.1007/s00405-007-0311-3. View

Maislin G, Pack A, Kribbs N, Smith P, Schwartz A, Kline L . A survey screen for prediction of apnea. Sleep. 1995; 18(3):158-66. DOI: 10.1093/sleep/18.3.158. View

Saini B, Krass I, Armour C . Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother. 2004; 38(11):1954-60. DOI: 10.1345/aph.1E045. View

Walters A, LeBrocq C, Dhar A, Hening W, Rosen R, Allen R . Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003; 4(2):121-32. DOI: 10.1016/s1389-9457(02)00258-7. View

de Souza L, Benedito-Silva A, Pires M, Poyares D, Tufik S, Calil H . Further validation of actigraphy for sleep studies. Sleep. 2003; 26(1):81-5. DOI: 10.1093/sleep/26.1.81. View

Kushida C, Chang A, Gadkary C, Guilleminault C, Carrillo O, Dement W . Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med. 2003; 2(5):389-96. DOI: 10.1016/s1389-9457(00)00098-8. View

10.

Gross C, Kreitzer M, Reilly-Spong M, Wall M, Winbush N, Patterson R . Mindfulness-based stress reduction versus pharmacotherapy for chronic primary insomnia: a randomized controlled clinical trial. Explore (NY). 2011; 7(2):76-87. PMC: 3077056. DOI: 10.1016/j.explore.2010.12.003. View

11.

McLean D, McAlister F, Johnson J, King K, Makowsky M, Jones C . A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008; 168(21):2355-61. DOI: 10.1001/archinte.168.21.2355. View

12.

Smith L, Bosnic-Anticevich S, Mitchell B, Saini B, Krass I, Armour C . Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Soc Sci Med. 2007; 64(7):1501-11. DOI: 10.1016/j.socscimed.2006.11.006. View

13.

Hillman D, Murphy A, Pezzullo L . The economic cost of sleep disorders. Sleep. 2006; 29(3):299-305. DOI: 10.1093/sleep/29.3.299. View

14.

ODonoghue G, Fox N, Heneghan C, Hurley D . Objective and subjective assessment of sleep in chronic low back pain patients compared with healthy age and gender matched controls: a pilot study. BMC Musculoskelet Disord. 2009; 10:122. PMC: 2765952. DOI: 10.1186/1471-2474-10-122. View

15.

Mehra R, Stone K, Ancoli-Israel S, Litwack-Harrison S, Ensrud K, Redline S . Interpreting wrist actigraphic indices of sleep in epidemiologic studies of the elderly: the Study of Osteoporotic Fractures. Sleep. 2008; 31(11):1569-76. PMC: 2579985. DOI: 10.1093/sleep/31.11.1569. View

16.

Johns M . Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest. 1993; 103(1):30-6. DOI: 10.1378/chest.103.1.30. View

17.

Hersberger K, Renggli V, Nirkko A, Mathis J, Schwegler K, Bloch K . Screening for sleep disorders in community pharmacies--evaluation of a campaign in Switzerland. J Clin Pharm Ther. 2006; 31(1):35-41. DOI: 10.1111/j.1365-2710.2006.00698.x. View

18.

Fuller J, Wong K, Krass I, Grunstein R, Saini B . Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia. Patient Educ Couns. 2011; 83(3):325-35. DOI: 10.1016/j.pec.2011.05.004. View

19.

Tran A, Fuller J, Wong K, Krass I, Grunstein R, Saini B . The development of a sleep disorder screening program in Australian community pharmacies. Pharm World Sci. 2009; 31(4):473-480. DOI: 10.1007/s11096-009-9301-4. View

20.

Littner M, Kushida C, Anderson W, Bailey D, Berry R, Davila D . Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep. 2003; 26(3):337-41. DOI: 10.1093/sleep/26.3.337. View